WINNERS & LOSERS: Red Capital secures funding; Supply@Me account delay
27th Apr 2026 11:24
(Alliance News) - The following are the leading risers and fallers among London Main Market small-cap and AIM stocks on Monday. Read More
(Alliance News) - The following are the leading risers and fallers among London Main Market small-cap and AIM stocks on Monday. Read More
(Alliance News) - The following are the leading risers and fallers among London Main Market small-cap and AIM stocks on Friday. Read More
(Alliance News) - The following are the leading risers and fallers among London Main Market small-cap and AIM stocks on Friday. Read More
(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News: Read More
(Alliance News) - Frontier IP Group PLC on Friday noted a jump in its share price, after one of its investees secured EU grant funding. Read More
(Alliance News) - The following are the leading risers and fallers among London Main Market small-cap and AIM stocks on Friday. Read More
(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News: Read More
(Alliance News) - Frontier IP Group PLC on Monday reported a wider pretax loss in its first half, driven by a mix of non-cash impairments and a net unrealised loss on its portfolio. Read More
(Alliance News) - Frontier IP Group PLC on Monday noted progress for portfolio company Alusid Ltd's European roll-out. Read More
(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Monday and not separately reported by Alliance News: Read More
<p> <table style="width: 790px;" border="0" cellspacing="0" cellpadding="0"><colgroup><col width="341" /> <col width="449" /> </colgroup><tbody><tr><td class="xl104" width="341" height="19"><strong>Thursday 25 December</strong></td><td width="449"> </td></tr><tr><td class="xl102" width="341" height="19">no events scheduled</td><td> </td></tr><tr><td class="xl104" height="19"><strong>Friday 26 December</strong></td><td> </td></tr><tr><td class="xl102" width="341" height="19">no events scheduled</td><td> </td></tr><tr><td class="xl104" height="19"><strong>Monday 29 December</strong></td><td> </td></tr><tr><td class="xl98" width="341" height="19">Allergy Therapeutics PLC</td><td class="xl98" width="449">GM re allotment of shares, pre-emption rights</td></tr><tr><td class="xl98" width="341" height="19">Goldplat PLC</td><td class="xl98" width="449">AGM</td></tr><tr><td class="xl99" width="341" height="19">SkinBioTherapeutics PLC</td><td class="xl99" width="449">AGM</td></tr><tr><td class="xl99" width="341" height="19">Synergia Energy Ltd</td><td class="xl99" width="449">GM re proposed cancellation of AIM shares in London</td></tr><tr><td class="xl99" width="341" height="19">Team PLC</td><td class="xl99" width="449">EGM re takeover of WH Ireland</td></tr><tr><td class="xl99" width="341" height="19">VVV Sports Ltd</td><td class="xl99" width="449">EGM re proposed acquisition of R3 Sport Ltd</td></tr><tr><td class="xl104" height="19"><strong>Tuesday 30 December</strong></td><td> </td></tr><tr><td class="xl98" width="341" height="19">Amazing AI PLC</td><td class="xl98" width="449">GM re cancellation from AQSE</td></tr><tr><td class="xl99" width="341" height="19">Bradda Head Lithium Ltd</td><td class="xl99" width="449">AGM</td></tr><tr><td class="xl98" width="341" height="19">Europa Oil & Gas Holdings PLC</td><td class="xl98" width="449">AGM</td></tr><tr><td class="xl98" width="341" height="19">Minoan Group PLC</td><td class="xl98" width="449">GM re proposed disposal of Loyalward Ltd</td></tr><tr><td class="xl99" width="341" height="19">Time To ACT PLC</td><td class="xl99" width="449">GM re FY25 accounts, auditors, buybacks, pre-emption rights</td></tr><tr><td class="xl98" width="341" height="19">Westminster Group PLC</td><td class="xl98" width="449">AGM</td></tr><tr><td class="xl98" width="341" height="19">Zentra Group PLC</td><td class="xl98" width="449">AGM</td></tr><tr><td class="xl98" width="341" height="19">80 Mile PLC</td><td class="xl98" width="449">GM re considering 2024 financial report</td></tr><tr><td class="xl98" width="341" height="19">Zambeef Products PLC</td><td class="xl98" width="449">AGM</td></tr><tr><td class="xl104" height="19"><strong>Wednesday 31 December</strong></td><td> </td></tr><tr><td class="xl98" width="341" height="19">Cardiogeni PLC</td><td class="xl98" width="449">AGM</td></tr><tr><td class="xl98" width="341" height="19">Frontier IP Group PLC</td><td class="xl98" width="449">AGM</td></tr><tr><td class="xl98" width="341" height="19">Iconic Labs PLC</td><td class="xl98" width="449">AGM</td></tr><tr><td class="xl102" width="341" height="19">Secure Property Development & Investment PLC</td><td class="xl100" width="449">AGM</td></tr><tr><td class="xl99" width="341" height="19">Starwood European Real Estate Finance Ltd</td><td class="xl99" width="449">EGM re extending financial year end to Feb 28 versus Dec 31 before, in connection with winding up of company</td></tr><tr><td class="xl99" width="341" height="19">t42 IoT Tracking Solutions PLC</td><td class="xl99" width="449">AGM</td></tr><tr><td class="xl98" width="341" height="21">Time Out Group PLC</td><td class="xl98" width="449">AGM</td></tr><tr><td class="xl103" width="341" height="21"> </td><td class="xl103" width="449"> </td></tr><tr><td class="xl101" colspan="2" height="20">A full 21-day events calendar is provided each day with a subscription to Alliance News UK Professional.</td></tr><tr><td height="21"> </td><td> </td></tr><tr><td class="xl101" colspan="2" height="21">Copyright 2025 Alliance News Ltd. All Rights Reserved.</td></tr></tbody></table></p> Read More
(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News: Read More
(Alliance News) - Frontier IP Group PLC on Monday said performance in financial 2025 was "solid" but was "hampered by difficult public and private market conditions." Read More
(Alliance News) - Stock prices in London were mostly lower at midday on Monday, ahead of US consumer inflation expectations and comments from the Bank of England's deputy governor. Read More
(Alliance News) - The following stocks are the leading risers and fallers on AIM on Monday. Read More
Frontier IP Group PLC - invests for income and growth in solar and battery storage assets - Portfolio company Alusid Ltd signs an exclusive distribution agreement with one of Sweden's largest tile suppliers Kakelspecialisten AB, a subsidiary of Courbevoie, France-based Compagnie de Saint Gobain SA. "The deal is a further sign of growing global interest in Alusid's sustainable wall and floor tiles and an important milestone in expanding its European distribution network," Frontier says. Frontier IP holds a 35% stake in Alusid. Read More
(Correcting that the announcements were made both on Monday and in the the past week.) Read More
(Alliance News) - The following is a round-up of London-listed company director and manager changes announced on Monday and not separately reported by Alliance News: Read More
(Alliance News) - Frontier IP Group PLC on Monday said its portfolio company Vaccine Group Ltd has achieved "outstanding" results in animal trials for two vaccine candidates targeting bovine respiratory syncytial virus (BRSV), a major livestock disease. Read More
Frontier IP Group PLC - London-based intellectual property commercialisation firm - Portfolio company Amprologix raises GBP740,000 to accelerate development of its novel antibiotics for antimicrobial-resistant diseases. Funds will go towards completion of the pre-clinical development of lead candidate epidermicin NI01, which is being developed to treat Methicillin-resistant Staphylococcus aureus, MRSA. Expects phase 1 human clinical trials to start next year. Says Amprologix is also preparing for a Series A funding round. Investors in the recent fundraise included individuals and "angel-investor network" Plutus Investment Group LLP. Plutus' Venture Partner Rita Dobmeyer will be joining Amprologix's board as a non-executive director to support clinical development. Frontier says Amprologix is also in the early stages of developing an antibiotic to treat and prevent Clostridioides difficile or C difficile infections. Read More